Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesThe economic implications of generic substitution of antiepileptic drugs: a review of recent evidence
Expert Opinion in Pharmacotherapy, 08/14/09
Duh MS et al. – Current literature suggests statistically higher overall healthcare costs during periods of generic AED use than during periods when branded AED are used, consistently demonstrated across different countries and in both stable and unstable epilepsy patients, with more pronounced cost increases in patients receiving multiple generic versions. Brand–to–generic substitutions of AEDs do not necessarily reduce overall healthcare costs and may even increase them.
Related Articles
Extended-Release Formulations of Antiepileptic Drugs: Rationale and Comparative Value
Epilepsy Currents, 10/30/09
Relevance Score: 67%
Bone Density of Ambulatory Adult Patients Receiving Long-term Anticonvulsant Drug Therapy
Archives of Iranian Medicine, 11/11/09
Relevance Score: 66%
Antiepileptic Drug Use, Falls, Fractures and BMD in Postmenopausal Women: Findings from the Womens Health Initiative (WHI)
Journal of Bone and Mineral Research, 10/28/09
Relevance Score: 66%
Opinion of Belgian neurologists on antiepileptic drug treatment in 2006: Belgian study on epilepsy treatment (BESET-2)
Acta Neurologica Scandinavica, 10/16/09
Relevance Score: 66%
Treatment For Epilepsy Is Possible Culprit For Development Of Schizophrenia
ScienceDaily, 10/26/09
Relevance Score: 65%
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Natalizumab treatment in multiple sclerosis: Marked decline of chemokines and cytokines in cerebrospinal fluid
Multiple Sclerosis, 12/11/09
Behavioral Dimensions and Acetylcholinesterase Inhibitor-related Effect in Alzheimer Disease Over Time: A Latent Trajectory Modeling
Cognitive and Behavioral Neurology, 12/11/09
Depression in Parkinson's Disease
Canadian Journal of Neurological Sciences, 12/10/09
Today in Pharmacoeconomics...keeping you current
Receive free subspecialty "5-minute updates" via email
Hospital visits and costs following outpatient treatment of CAP with levofloxacin or moxifloxacin
Current Medical Research and Opinion, 12/11/09
Economic consequences of ACS-related rehospitalizations in the US
Current Medical Research and Opinion, 12/10/09
Out-of-pocket Prices of Opioid Analgesics in the United States, 1999–2004
Pain Medicine, 12/10/09
Sponsor
Article Search
Sponsor
Sponsor